• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » WIRB Copernicus Group acquires ePharmaSolutions

WIRB Copernicus Group acquires ePharmaSolutions

September 24, 2014
CenterWatch Staff

WIRB Copernicus Group, after acquiring three IRBs in the past four months, is continuing its spending spree, expanding into a new area with the purchase of ePharmaSolutions (ePS) of Plymouth Meeting, Pa.

The 14-year-old company is a provider of eClinical solutions and technology-enabled services including its cloud-based enterprise Clinical Trial Portal (CTP) and Electronic Trial Master File (eTMF), which are used by 350,000 clinical professionals in 130 countries. Both proprietary programs are designed to improve coordination of study start-up, site management and regulatory document control.

Terms of the acquisition were not disclosed.

“For WIRB Copernicus Group, ePharmaSolutions is the start of a separate division that will continue to operate independently,” said Donald A. Deieso, Ph.D., WCG chairman and CEO. “Using ePS’ leading technology-driven solutions to assure that the activities of trial sites are coordinated, well informed and efficiently managed will result in significant benefits to pharmaceutical companies, CROs, institutions and subjects. Improving clinical trials is a cornerstone of WCG’s mission.”

Deieso said ePS—its fifth acquisition this year—continues the overall mission to reduce the time, cost and administrative burden of clinical research using technology that can help eliminate delays and reduce costs.

For Lance Converse, founder and CEO of ePharmaSolutions, joining WCG fulfills his company’s goal of improving the clinical trial process with a larger partner after developing an eClinical portal platform. 

“Don [Deieso] and I saw from our first meeting that we could work collectively to streamline—through technology—a major part of the IRB process,” said Converse.

Earlier this month, at the Disruptive Innovations to Advance Clinical Trials conference in Boston, ePS was awarded “Disruptive Innovator of the Year” for its ePharmONE cloud-based eClinical platform.

For WCG, ePS is its second non-IRB acquisition, following the July addition of Alliance Biosciences, a bio-safety and bio-security consulting firm now part of the WCG Biosafety division. Alliance Bioscience, a former division of Alliance Engineering, covers all aspects of the bio-safety review process, from building the laboratories and organizing materials to managing the regulatory review boards and the ethical approval process for drugs in development.

WCG also has acquired three IRBS over the past few months—New England IRB (NEIRB) of Newton, Mass., this month; and Midlands IRB of Kansas City, Mo., and San Diego-based Aspire IRB, both in June. WCG—which also includes the earlier acquisition of IRBNet plus original companies Western IRB and Copernicus IRB—provides members  with access to capital, training and business and science expertise, along with expanded marketing and sales, to allow them to accelerate growth. 

For more on this story, see next Monday's CWWeekly.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing